Literature DB >> 19578037

Novel FOXG1 mutations associated with the congenital variant of Rett syndrome.

M A Mencarelli1, A Spanhol-Rosseto, R Artuso, D Rondinella, R De Filippis, N Bahi-Buisson, J Nectoux, R Rubinsztajn, T Bienvenu, A Moncla, B Chabrol, L Villard, Z Krumina, J Armstrong, A Roche, M Pineda, E Gak, F Mari, F Ariani, A Renieri.   

Abstract

BACKGROUND: Rett syndrome is a severe neurodevelopmental disorder representing one of the most common genetic causes of mental retardation in girls. The classic form is caused by MECP2 mutations. In two patients affected by the congenital variant of Rett we have recently identified mutations in the FOXG1 gene encoding a brain specific transcriptional repressor, essential for early development of the telencephalon.
METHODS: 60 MECP2/CDKL5 mutation negative European Rett patients (classic and variants), 43 patients with encephalopathy with early onset seizures, and four atypical Rett patients were analysed for mutations in FOXG1. RESULTS AND
CONCLUSIONS: Mutations have been identified in four patients, independently classified as congenital Rett variants from France, Spain and Latvia. Clinical data have been compared with the two previously reported patients with mutations in FOXG1. In all cases hypotonia, irresponsiveness and irritability were present in the neonatal period. At birth, head circumference was normal while a deceleration of growth was recognised soon afterwards, leading to severe microcephaly. Motor development was severely impaired and voluntary hand use was absent. In contrast with classic Rett, patients showed poor eye contact. Typical stereotypic hand movements with hand washing and hand mouthing activities were present continuously. Some patients showed abnormal movements of the tongue and jerky movements of the limbs. Brain magnetic resonance imaging showed corpus callosum hypoplasia in most cases, while epilepsy was a variable sign. Scoliosis was present and severe in the older patients. Neurovegetative symptoms typical of Rett were frequently present.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19578037     DOI: 10.1136/jmg.2009.067884

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  44 in total

1.  Testing for Ancient Selection Using Cross-population Allele Frequency Differentiation.

Authors:  Fernando Racimo
Journal:  Genetics       Date:  2015-11-23       Impact factor: 4.562

2.  FoxG1 promotes the survival of postmitotic neurons.

Authors:  Somasish Ghosh Dastidar; Paul Michael Zagala Landrieu; Santosh R D'Mello
Journal:  J Neurosci       Date:  2011-01-12       Impact factor: 6.167

3.  Foxg1 has an essential role in postnatal development of the dentate gyrus.

Authors:  Chuanxi Tian; Yifan Gong; Ying Yang; Wei Shen; Kun Wang; Junhua Liu; Bokai Xu; Jing Zhao; Chunjie Zhao
Journal:  J Neurosci       Date:  2012-02-29       Impact factor: 6.167

4.  14q12 and severe Rett-like phenotypes: new clinical insights and physical mapping of FOXG1-regulatory elements.

Authors:  Lila Allou; Laetitia Lambert; Daniel Amsallem; Eric Bieth; Patrick Edery; Anne Destrée; François Rivier; David Amor; Elizabeth Thompson; Julian Nicholl; Michael Harbord; Christophe Nemos; Aline Saunier; Aissa Moustaïne; Adeline Vigouroux; Philippe Jonveaux; Christophe Philippe
Journal:  Eur J Hum Genet       Date:  2012-06-27       Impact factor: 4.246

5.  Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications.

Authors:  Przemyslaw Szafranski; Sailaja Golla; Weihong Jin; Ping Fang; Patricia Hixson; Reuben Matalon; Daniel Kinney; Hans-Georg Bock; William Craigen; Janice L Smith; Weimin Bi; Ankita Patel; Sau Wai Cheung; Carlos A Bacino; Paweł Stankiewicz
Journal:  Eur J Hum Genet       Date:  2014-10-15       Impact factor: 4.246

6.  The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis.

Authors:  Fanny Kortüm; Soma Das; Max Flindt; Deborah J Morris-Rosendahl; Irina Stefanova; Amy Goldstein; Denise Horn; Eva Klopocki; Gerhard Kluger; Peter Martin; Anita Rauch; Agathe Roumer; Sulagna Saitta; Laurence E Walsh; Dagmar Wieczorek; Gökhan Uyanik; Kerstin Kutsche; William B Dobyns
Journal:  J Med Genet       Date:  2011-03-25       Impact factor: 6.318

7.  FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders.

Authors:  Jessica Mariani; Gianfilippo Coppola; Ping Zhang; Alexej Abyzov; Lauren Provini; Livia Tomasini; Mariangela Amenduni; Anna Szekely; Dean Palejev; Michael Wilson; Mark Gerstein; Elena L Grigorenko; Katarzyna Chawarska; Kevin A Pelphrey; James R Howe; Flora M Vaccarino
Journal:  Cell       Date:  2015-07-16       Impact factor: 41.582

8.  Duplications of FOXG1 in 14q12 are associated with developmental epilepsy, mental retardation, and severe speech impairment.

Authors:  Nicola Brunetti-Pierri; Alex R Paciorkowski; Roberto Ciccone; Erika Della Mina; Maria Clara Bonaglia; Renato Borgatti; Christian P Schaaf; V Reid Sutton; Zhilian Xia; Naftha Jelluma; Claudia Ruivenkamp; Mary Bertrand; Thomy J L de Ravel; Parul Jayakar; Serena Belli; Katia Rocchetti; Chiara Pantaleoni; Stefano D'Arrigo; Jeff Hughes; Sau Wai Cheung; Orsetta Zuffardi; Pawel Stankiewicz
Journal:  Eur J Hum Genet       Date:  2010-08-25       Impact factor: 4.246

Review 9.  A FOXG1 mutation in a boy with congenital variant of Rett syndrome.

Authors:  Tangui Le Guen; Nadia Bahi-Buisson; Juliette Nectoux; Nathalie Boddaert; Yann Fichou; Bertrand Diebold; Isabelle Desguerre; Florence Raqbi; Valérie Cormier Daire; Jamel Chelly; Thierry Bienvenu
Journal:  Neurogenetics       Date:  2010-08-24       Impact factor: 2.660

10.  14q12 microdeletions excluding FOXG1 give rise to a congenital variant Rett syndrome-like phenotype.

Authors:  Carolyn J Ellaway; Gladys Ho; Elisa Bettella; Alisa Knapman; Felicity Collins; Anna Hackett; Fiona McKenzie; Artur Darmanian; Gregory B Peters; Kerry Fagan; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2012-09-12       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.